← Back to Analyst Consensus 
EFX Buy
EQUIFAX INC
Current Price —
Implied Upside —
Analysts 30
30-Day Momentum
▲ 1 upgrades / ▼ 1 downgrades / 9 reiterations from 9 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 22, 2026 | Argus Research | upgrade | Hold → Buy | — | 53% |
| Oct 21, 2026 | BMO Capital | maintain | Market Perform → Market Perform | — | 53% |
| Oct 21, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Oct 21, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Oct 19, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Oct 16, 2026 | Oppenheimer | downgrade | Outperform → Perform | — | 52% |
| Oct 16, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Oct 13, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Oct 13, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Oct 2, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Sep 30, 2026 | BMO Capital | maintain | Market Perform → Market Perform | — | 53% |
| Sep 22, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Aug 21, 2026 | Rothschild & Co | upgrade | Neutral → Buy | — | 56% |
| Jul 22, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 22, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jul 22, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Jul 22, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 22, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jul 22, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 8, 2026 | UBS | reiterate | Buy → Buy | — | 54% |
| Jul 7, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Jul 2, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 2, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jun 18, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jun 16, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 19, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Apr 27, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Apr 23, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 22, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Apr 22, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Apr 22, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Apr 16, 2026 | Mizuho | initiate | — → Outperform | — | 52% |
| Apr 13, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Feb 9, 2026 | Goldman Sachs | maintain | Neutral → Neutral | $208 | 54% |
| Feb 5, 2026 | JP Morgan | maintain | Overweight → Overweight | $230 | 54% |
| Feb 5, 2026 | Stifel | maintain | Buy → Buy | $235 | 53% |
| Feb 5, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | $215 | 53% |
| Feb 5, 2026 | RBC Capital | maintain | Outperform → Outperform | $222 | 55% |
| Feb 5, 2026 | Wells Fargo | maintain | Overweight → Overweight | $240 | 54% |
| Feb 5, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $244 | 54% |
| Feb 5, 2026 | Needham | maintain | Buy → Buy | $265 | 50% |
| Jan 14, 2026 | Wells Fargo | maintain | Overweight → Overweight | $265 | 54% |
| Jan 12, 2026 | Oppenheimer | maintain | Outperform → Outperform | $266 | 52% |
| Dec 17, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $280 | 54% |
| Dec 8, 2025 | BMO Capital | maintain | Market Perform → Market Perform | $234 | 53% |
| Oct 22, 2025 | Stifel | maintain | Buy → Buy | $253 | 53% |
| Oct 22, 2025 | BMO Capital | maintain | Market Perform → Market Perform | $245 | 53% |
| Oct 21, 2025 | Needham | reiterate | Buy → Buy | $295 | 50% |
| Oct 15, 2025 | Wells Fargo | maintain | Overweight → Overweight | $285 | 54% |
| Oct 8, 2025 | Needham | reiterate | Buy → Buy | $295 | 50% |
Price Target Trend
Jul 20, 2026 Latest: $198.4 Oct 25, 2026
EPS Estimates
0y $8.50
Lo: $8.37 Hi: $8.71
23 analysts 0q $2.13
Lo: $2.08 Hi: $2.20
19 analysts +1y $9.57
Lo: $9.00 Hi: $10.70
20 analysts +1q $1.93
Lo: $1.78 Hi: $2.07
16 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days